Stock Screener App

Gratuito -

Installare

6.66

0.45% 0.03

Lexeo Therapeutics Inc (LXEO)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Lexeo Therapeutics Inc Azioni (LXEO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	29.46% 21.65	30.69	33.80	27.38	31.54
Depreciation and Amortization	17.74% 0.073	0.062	0.06	0.075	0.083
Operating Income/Loss	29.46% -21.65	-30.69	-33.80	-27.38	-31.54
Nonoperating Income/Loss	70.23% 1.365	4.585	1.149	1.458	2.054
Income/Loss From Continuing Operations Before Tax	22.30% -20.28	-26.10	-32.66	-25.92	-29.49
Income/Loss From Continuing Operations After Tax	22.30% -20.28	-26.10	-32.66	-25.92	-29.49
Net Income/Loss	22.30% -20.28	-26.10	-32.66	-25.92	-29.49
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	39.95% 60.98	43.57	33.11	0.4327	33.06
Diluted Average Shares	39.95% 60.98	43.57	33.11	0.4327	33.06
Basic Earnings Per Share	45.00% -0.33	-0.60	-0.99	-0.78	-0.89
Diluted Earnings Per Share	45.00% -0.33	-0.60	-0.99	-0.78	-0.89
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters